Scilex Holding (SCLXW) Capital Expenditures (2022 - 2026)
Scilex Holding (SCLXW) recorded quarterly Capital Expenditures of $200000.0 in Q1 2026, up 19900.0% quarter-over-quarter from $1000.0 in Q4 2023.
Scilex Holding (SCLXW) Capital Expenditures (2022 - 2026) Analysis & Trends
Scilex Holding's Capital Expenditures history runs 3 years deep, the most recent figure standing at $200000.0 for Q1 2026.
- In Q1 2026, Capital Expenditures changed N/A year-over-year to $200000.0; the TTM figure through Mar 2026 stood at $200000.0 (up 19900.0% YoY), while the FY2025 annual figure was $133000.0, changed N/A from the prior year.
- Capital Expenditures was $200000.0 for Q1 2026 at Scilex Holding, up from $1000.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $200000.0 in Q1 2026 to a low of $1000.0 in Q4 2023.
- Historically, Capital Expenditures has averaged $57250.0 across 3 years, with a median of $14000.0 in 2022.
- Biggest YoY gain for Capital Expenditures was 200.0% in 2023; the steepest drop was 200.0% in 2023.
- A 3-year view of Capital Expenditures shows it stood at $7000.0 in 2022, then slumped by 85.71% to $1000.0 in 2023, then jumped by 19900.0% to $200000.0 in 2026.
- The last three Capital Expenditures figures came in at $200000.0 (Q1 2026), $1000.0 (Q4 2023), and $21000.0 (Q3 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | -297.95 Mn |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 2.33 Bn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 1.05 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 265.00 Mn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | 991.00 Mn |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 712.00 Mn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 117.00 Mn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 436.00 Mn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | 347.00 Mn |
| 10 | Scilex Holding | - | - | 4.15 Mn | 200,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 200,000.00 |
| Mar 31, 2026 | 200,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Dec 31, 2023 | 1,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Sep 30, 2023 | 21,000.00 |
| Sep 30, 2022 | 7,000.00 |
| Sep 30, 2022 | 7,000.00 |